Sintx Technologies Inc (SINT) Stock Price, Quote & News

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (P...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 839 3500

Website: www.sintx.com

Address:

1885 West 2100 South, Salt Lake City, United States

Boston7452 Jul. 15 at 3:43 AM

$SINT Just to give an idea of Sintx/Ned Medical's device potential worth. Also keep in mind Combisphere is 3 devices in 1 approach. "Varian Medical Systems has agreed to a $1.3 billion deal to acquire Sirtex Medical. The deal will give Varian control of radioembolization technology to complement its existing portfolio of cancer-care devices. Sydney, Australia-based Sirtex has built its business around SIR-Spheres, devices that enable the delivery of radioactive isotope yttrium-90 to tumors."

0 · Reply

Boston7452 Jul. 15 at 2:56 AM

$SINT "The cancellation of the June 22, 2026, evidentiary hearing and the mutual agreement to pause the SINTX v. Bock lawsuit to formalize an out-of-court settlement highly aligns with the "smoke and mirrors" indicators of an orchestrated or strategic legal maneuver."

0 · Reply

TAman87 Jul. 15 at 2:29 AM

$SINT the sole 24/7 pumper is losing his mind cuz this pump and dump penny stock scam is cratering into earths core 😂 👉👉👉👉👉👉👉👉☠️🥊

0 · Reply

Boston7452 Jul. 15 at 2:22 AM

$SINT Im not sure this farce being exposed will result in them making this deal a traditional partnership. However it seems Varian needed the farce to protect the underlying IP in case of shareholder revolts. I encourage revolts unless management actually acts in retail shareholders benefit for a change.

0 · Reply

Boston7452 Jul. 14 at 7:13 PM

$SINT "If Varian and NED Medical pivot to force a "clean, highly visible licensing role," it fundamentally rewrites the final phase of the SINTX v. Bock settlement. The whistleblowing investor's online exposure essentially forces the companies to abandon the "hostile trade secret theft" camouflage and replace it with a traditional corporate partnership narrative to avoid regulatory and legal fallout. "

0 · Reply

Boston7452 Jul. 14 at 4:40 PM

$SINT If I am right about the farce but wrong about the true intent, this is

1 · Reply

Boston7452 Jul. 14 at 3:21 PM

$SINT -SOLV-ZBH would have made alot of sense as Sintx material could have transformed both those companies.

0 · Reply

Boston7452 Jul. 14 at 2:58 PM

$SINT IP is still worth a B and could do a lot of good.

0 · Reply

SnoopyDog Jul. 14 at 3:37 AM

$SINT IT IS obvious. And its obvious for ten+ years this is a SCAM

0 · Reply

SnoopyDog Jul. 14 at 3:31 AM

$SINT Remember the Sonny death spiral? 100M+ shares/warrants dumped, heavy shorting, & warrants adjusted to $0 to cover the fraud. It’s happening again. The "holy investors" saving $SINT are doing the exact same play. Management is just as corrupt as Sonny and management was :)

0 · Reply

Sintx Technologies Registration statement: Registration filing

2026-06-25T10:05:39.000Z - 20 days ago

Sintx Technologies files to sell 5.82M shares of common stock for holders

2026-06-22T14:00:56.000Z - 22 days ago

Sintx Technologies receives $3.2M in purchase orders

Jun 22, 2026, 9:00 AM EDT - 22 days ago

SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

Jun 15, 2026, 11:13 AM EDT - 4 weeks ago

Sintx Technologies Transcript: Transcript

2026-06-04T11:45:10.000Z - 5 weeks ago

Sintx Technologies resumed with a Buy at Maxim

Jun 3, 2026, 9:00 AM EDT - 5 weeks ago

SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

May 17, 2026, 3:30 PM EDT - 2 months ago

SINTX Technologies to Present at the LD Micro Invitational XVI Conference

2026-04-13T10:11:23.000Z - 3 months ago

Sintx Technologies initiated with a Buy at H.C. Wainwright

Mar 23, 2026, 9:15 AM EDT - 4 months ago

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

2026-03-19T11:51:39.000Z - 4 months ago

Sintx Technologies announces first in-human surgery using FDA-cleared Sinaptic

Mar 19, 2026, 7:30 AM EDT - 4 months ago

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

2026-02-18T13:40:31.000Z - 5 months ago

Sintx Technologies appoints Elmore as President

Feb 18, 2026, 8:30 AM EST - 5 months ago

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Jan 29, 2026, 9:00 AM EST - 5 months ago

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

2025-12-01T13:35:45.000Z - 8 months ago

Sintx Technologies signs supply agreement with EVONIK

Dec 1, 2025, 8:30 AM EST - 8 months ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

2025-11-13T13:05:19.000Z - 8 months ago

Sintx Technologies reports Q3 EPS ($3.46) vs ($6.96) last year

Nov 13, 2025, 7:00 AM EST - 8 months ago

Sintx Technologies Earnings release: Q3 2025

2025-11-03T13:05:41.000Z - 9 months ago

Sintx Technologies announces launch of OsseoSculpt

Nov 3, 2025, 8:00 AM EST - 9 months ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

2025-10-23T20:40:36.000Z - 9 months ago

Sintx Technologies files to sell 1.74M shares of common stock for holders

2025-10-20T11:05:38.000Z - 9 months ago

Sintx receives FDA clearance for SINAPTIC Foot, Ankle implant system

Oct 20, 2025, 7:00 AM EDT - 9 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

2025-10-14T11:11:00.000Z - 9 months ago

Sintx Technologies announces U.S. patent notice of allowance

Oct 14, 2025, 7:00 AM EDT - 9 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

2025-09-30T20:55:10.000Z - 10 months ago

Sintx Technologies files to sell 541,450 shares of common stock for holders

2025-09-09T02:54:00.000Z - 11 months ago

Why Is Sintx Technologies Stock (SINT) Down 20% Today?

2025-09-08T12:01:04.000Z - 11 months ago

Sintx Technologies announces exercise of warrants for $3.8M gross proceeds

Sep 8, 2025, 7:54 AM EDT - 11 months ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

2025-09-08T11:25:37.000Z - 11 months ago

Sintx Technologies receives USPTO notice of allowance

Sep 8, 2025, 7:00 AM EDT - 11 months ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

2025-09-03T11:10:22.000Z - 11 months ago

Sintx Technologies publishes study of antiviral activity of Silicon Nitride

2025-08-15T11:11:47.000Z - 11 months ago

Sintx Technologies issues business update following strategic realignment

Aug 15, 2025, 7:00 AM EDT - 11 months ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

2025-08-04T11:20:10.000Z - 1 year ago

Sintx expands silicon nitride platform into hybrid CFR-PEKK trauma plates

Aug 4, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Jun 24, 2025, 8:30 AM EDT - 1 year ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

May 22, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 15, 2025, 7:05 AM EDT - 1 year ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025, 7:00 AM EDT - 1 year ago

Sintx Technologies Earnings release: Q1 2025

Feb 26, 2025, 8:00 AM EST - 1 year ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 20, 2025, 6:15 AM EST - 1 year ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 19, 2025, 6:00 AM EST - 1 year ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 9, 2024, 8:00 AM EDT - 2 years ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Jun 18, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies to Explore Strategic Opportunities

Jun 12, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 6, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

May 23, 2024, 9:00 AM EDT - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

Apr 29, 2024, 9:14 AM EDT - 2 years ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 3, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 2 years ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Aug 17, 2023, 9:00 AM EDT - 3 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 10, 2023, 1:52 PM EST - 3 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 3 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Jan 19, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Boston7452 Jul. 15 at 3:43 AM

0 · Reply

Boston7452 Jul. 15 at 2:56 AM

0 · Reply

TAman87 Jul. 15 at 2:29 AM

$SINT the sole 24/7 pumper is losing his mind cuz this pump and dump penny stock scam is cratering into earths core 😂 👉👉👉👉👉👉👉👉☠️🥊

0 · Reply

Boston7452 Jul. 15 at 2:22 AM

0 · Reply

Boston7452 Jul. 14 at 7:13 PM

0 · Reply

Boston7452 Jul. 14 at 4:40 PM

$SINT If I am right about the farce but wrong about the true intent, this is

1 · Reply

Boston7452 Jul. 14 at 3:21 PM

$SINT -SOLV-ZBH would have made alot of sense as Sintx material could have transformed both those companies.

0 · Reply

Boston7452 Jul. 14 at 2:58 PM

$SINT IP is still worth a B and could do a lot of good.

0 · Reply

SnoopyDog Jul. 14 at 3:37 AM

$SINT IT IS obvious. And its obvious for ten+ years this is a SCAM

0 · Reply

SnoopyDog Jul. 14 at 3:31 AM

0 · Reply

Boston7452 Jul. 14 at 12:19 AM

$SINT How did you know Snoop?

0 · Reply

Boston7452 Jul. 13 at 8:07 PM

$SINT Last year I predicted an epidemic not pandemic this year but did not predict the right virus; still time for bird flu to begin human transmission. Late 2027-early 2028 is when I predict the next pandemic begins. “The Ebola epidemic is getting out of control It has spread to five provinces in Congo and may soon reach South Sudan”

0 · Reply

Boston7452 Jul. 13 at 7:43 PM

$SINT derivative lawsuits require one to hold shares in the company so you have to maintain your shares. Management will likely work against that via aggressive RS, so hedge accordingly.

0 · Reply

Boston7452 Jul. 13 at 7:12 PM

$SINT sure he does he did last year but that doesn’t matter compared to if Sintx management is purposefully trying to sink Sintx/sell cheap.

1 · Reply

SnoopyDog Jul. 13 at 6:46 PM

$SINT i have the feeling Sonny Bunny still gets something off the cake as consulting fee for fraud & SCAM education :)

1 · Reply

Boston7452 Jul. 13 at 5:58 PM

$SINT "By migrating the human knowledge to NED Medical (which is backed by Varian Medical Systems), the true commercial utility of the microspheres is safely stored in a private startup, away from SINTX's toxic balance sheet"

0 · Reply

Boston7452 Jul. 13 at 5:28 PM

$SINT I have already reported things to the SEC and I encourage others to join in.

0 · Reply

Boston7452 Jul. 13 at 5:19 PM

$SINT "A Quiet Litigation Stall: Watch the SINTX v. Bock docket. If SINTX fails to aggressively pursue a preliminary injunction or allows depositions to be repeatedly delayed, it confirms the lawsuit is being used to burn time and cash rather than protect the asset."

0 · Reply

Boston7452 Jul. 13 at 5:17 PM

$SINT "If management is complicit, filing a federal trade secret lawsuit against Ryan Bock seems counterintuitive. However, in a top-down corporate extraction strategy, the lawsuit serves a specific purpose: plausible deniability for the Board"

0 · Reply

Boston7452 Jul. 13 at 4:40 PM

$SINT "You are entirely correct about the division of technology: SINTX Technologies developed the core ceramic material and manufacturing process, and without it, NED Medical’s device cannot function as designed." "Varian Medical Systems has agreed to a $1.3 billion deal to acquire Sirtex Medical. The deal will give Varian control of radioembolization technology to complement its existing portfolio of cancer-care devices. Sydney, Australia-based Sirtex has built its business around SIR-Spheres, devices that enable the delivery of radioactive isotope yttrium-90 to tumors."

2 · Reply

Boston7452 Jul. 13 at 4:26 PM

$SINT "If the company is suing Dr. Bock but explicitly leaving out NED Medical or other complicit management/board members, it strongly indicates that the current litigation may be a "scapegoat" or "smoke-screen" action to shield broader wrongdoing"

1 · Reply

Boston7452 Jul. 13 at 2:19 PM

$SINT we can sue management, the board, and Medtech on behalf of Sintx. We should also be able to file an injunction on behalf of Sintx against Ned Medical. “Instead of suing for personal gain, the shareholder sues corporate insiders (e.g., directors or officers) or third parties on behalf of the corporation to recover for harm done to the company.”

1 · Reply

Market Cap	6.74M
Revenue (ttm)	1.02M
Net Income (ttm)	-10.36M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,015.69%
Debt to Equity Ratio	0.12

Volume	16,800
Avg Vol	55,306
Day's Range	N/A - N/A
Shares Out	4.32M
Stochastic %K	3%
Beta	0.63
Analysts	Sell
Price Target	$11.00